Compare NBN & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBN | ATEC |
|---|---|---|
| Founded | 1872 | 1990 |
| Country | United States | United States |
| Employees | 234 | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | N/A | 2006 |
| Metric | NBN | ATEC |
|---|---|---|
| Price | $130.50 | $9.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 11 |
| Target Price | ★ $130.50 | $22.00 |
| AVG Volume (30 Days) | 99.6K | ★ 2.2M |
| Earning Date | 04-27-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.03% | N/A |
| EPS Growth | N/A | ★ 15.04 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $101,739,000.00 |
| Revenue This Year | $13.77 | $18.97 |
| Revenue Next Year | $18.72 | $16.70 |
| P/E Ratio | $11.29 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $80.75 | $6.82 |
| 52 Week High | $142.31 | $23.29 |
| Indicator | NBN | ATEC |
|---|---|---|
| Relative Strength Index (RSI) | 47.77 | 49.52 |
| Support Level | $127.84 | $8.90 |
| Resistance Level | $137.75 | $9.75 |
| Average True Range (ATR) | 2.97 | 0.44 |
| MACD | -0.49 | -0.05 |
| Stochastic Oscillator | 23.82 | 28.19 |
Northeast Bank provides banking and financial services to individual and corporate customers in the United States. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived principally from interest and dividends from the bank.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.